Research

HLH, a rare disorder of the immune system, is caused by a buildup of proteins responding to infection. Read about a new treatment that limits that buildup.

Researchers learn how this housekeeper for cancer cells turns into a cancer house killer. Learn how targeting LAP could promote an anti-tumor response and slow tumor growth.

This new cancer algorithm shows possible precision options for cancer treatment.

This shape-shifting cipher of the cell may hold the key to curing cancer through causing cancer cells to kill themselves.

How close are we to another deadly influenza virus pandemic? Read about how scientists are figuring out how to prevent the next catastrophe.

Newly approved Vitrakvi (larotrectinib) scored high patient response rates by inhibiting a rare chromosomal abnormality that drives tumor growth.

Will a new genome sequencing data mining technique reveal the mother lode of secrets for treating cancer and other catastrophic diseases?

A recently discovered mutation that occurs when the flu virus is exposed Xofluza could also cause drug resistance.

For 12 years, science didn’t know how certain immune responses were activated. They do now, and it may lead to new cancer treatments.

New findings from St. Jude study Genomes 4 Kids suggest many actionable mutations are missed without a three-platform genomic sequencing approach that includes WGS.